Key Market Indicators
Kuwait's insulin import is projected to surge to approximately $43.5 million by 2028, up from around $37.5 million in 2023. This marks an average annual growth rate of 2.3%. Since 2011, the demand for insulin in Kuwait has consistently increased by 2.3% each year. However, during the same period, the domestic supply of insulin has seen a significant decline, dropping by 21% annually. The contrasting trends highlight Kuwait's growing reliance on imported insulin to meet its healthcare needs.
